The FDA warned a compounder linked to Hims over unsanitary conditions while making unapproved versions of Wegovy, highlighting safety risks with compounded weight‑loss drugs. Here's more on this. #DrugSafety #FDA #Pharma #WeightLoss statnews.com/pharmalot/2026…

Leading medical societies say evidence for gender-affirming surgeries in minors is limited and recommend generally delaying such procedures until adulthood. Here's more on this. #HealthCare #MedicalCare #AdolescentHealth statnews.com/2026/02/10/med…

A federal settlement confirms that needle exchange programs are protected under the Americans with Disabilities Act, reinforcing legal support for harm-reduction services. Here's more on this. #PublicHealth #HarmReduction #ADA #HealthEquity statnews.com/2026/02/10/nee…

New data show that many people who get lung cancer never smoked, highlighting gaps in current screening guidelines. Here's more on this. #LungCancer #Screening #PublicHealth statnews.com/2026/02/11/lun…

New data suggest more people are smoking fentanyl instead of injecting it, and harm-reduction outreach with safer smoking supplies may be linked to drops in overdose deaths. Read more. #PublicHealth #HarmReduction #AddictionCare statnews.com/2026/02/12/fen…

Early trial results suggest Compass Pathways’ COMP360 psilocybin therapy may help treat severe depression, adding momentum to psychedelic mental health research. Here's more on this. #MentalHealth #Depression #ClinicalTrials statnews.com/2026/02/17/com…

A key CDC vaccine advisory meeting may be postponed, raising questions about timing for important immunization recommendations. Here's more on this. #Vaccines #PublicHealth #CDC statnews.com/2026/02/18/cdc…

Startups are pitching advanced semen analysis as a male equivalent to the Pap smear, aiming to improve early detection of reproductive health issues. Read more on this. #MensHealth #HealthTech #ReproductiveCare statnews.com/2026/02/19/sem…

New questions are being raised about a study suggesting cancer immunotherapy works better when given in morning hours, highlighting the need for careful interpretation of early findings. Here's more. #CancerResearch #Immunotherapy #Science statnews.com/2026/02/20/can…

New results from the GRAIL Galleri multi-cancer early detection test show promise in identifying multiple cancers early, a potential step forward in screening innovation. Here's more on this. #CancerScreening #EarlyDetection #HealthTech statnews.com/2026/02/19/gra…

Questions are emerging about a study suggesting cancer immunotherapy works better with morning infusions, a reminder to interpret early findings carefully. Here's more on this. #CancerResearch #Immunotherapy #ScienceNews statnews.com/2026/02/20/can…

Gossamer’s drug failed its lung disease study but the company still plans to pursue FDA approval — a reminder that setbacks in clinical trials don’t always end the development journey. Here's more. #ClinicalTrials #DrugDevelopment #RespiratoryHealth statnews.com/2026/02/23/gos…

Big pharma is racing to develop IBD combination therapies, with AbbVie, Lilly, Pfizer, Merck, and J&J all advancing programs that could expand treatment options for patients. Here's more. #IBD #Pharma #HealthcareInnovation statnews.com/2026/02/24/ibd…

The FDA has cleared a new treatment for a rare disease caused by EBV, offering hope where options were limited and highlighting progress in targeted therapies. Here's more on this. #RareDisease #FDA #Biotech #HealthInnovation statnews.com/2026/02/25/rar…

The FDA is facing questions about how to regulate brain-computer interfaces, balancing innovation with safety as these technologies advance. Here's more on this. #HealthTech #FDA #BCI #Innovation statnews.com/2026/02/26/bra…

New research highlights gaps in men’s sexual and reproductive health, including contraception and STI prevention, and urges more focus on services and studies tailored to men’s needs. Here's more on this. #MensHealth #ReproductiveHealth #PublicHealth statnews.com/2026/02/27/men…

Two new members have been added to the CDC’s vaccine advisory committee (ACIP), bringing fresh expertise to national immunization discussions. Here's more on this. #Vaccines #PublicHealth #CDC statnews.com/2026/02/27/two…

The “godfather of vaccines,” Stanley Plotkin, reflects on the field’s progress and current challenges, sharing concerns about vaccine hesitancy and the future of immunization science. Read more on this. #Vaccines #PublicHealth #Immunization statnews.com/2026/03/02/sta…

Trump’s push to tie U.S. drug prices to Europe’s most‑favored nation pricing has created uncertainty overseas, with questions about confidentiality, potential price shifts, and access as details of the deals remain unclear. Here's more. statnews.com/2026/03/02/tru…

Medicare’s drug price negotiation program could lower costs for cancer treatments, but experts warn the way doses are counted may affect how much savings patients and the program actually see. #Medicare #CancerCare #Pharma statnews.com/2026/03/03/med…